Fulgent Genetics Follow Verify

www.fulgentgenetics.com
Fulgent Genetics
Type	Public
Industry	Biotechnology
Founded	2011
Headquarters	Temple City, California 91780 United States
Key people	Ming Hsieh (CEO), Han Lin Gao ( Chief Scientific Officer), Paul Kim (CFO)

Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics. It focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016.
They have Accreditations from the following:

• Clinical Laboratory Improvement Amendments (CLIA) License 2015-2017
• College of American Pathologists (CAP) Accreditation 2017
• California Clinical Laboratory License 2016
• Florida Clinical Laboratory License 2016 - 2018
• Pennsylvania Clinical Laboratory Permit 2016-2017
• Maryland Medical Laboratory License 2015-2016

Top 5 Recent Tweets

Date	Author	Comment
October 21, 2020	dakotafinancial	Zacks Investment Research Downgrades Fulgent Genetics $FLGT to Hold https://t.co/iWYNsnvmhr
October 21, 2020	ZolmaxNews	Short Interest in Fulgent Genetics, Inc. $FLGT Expands By 23.9% https://t.co/Wpq32doUXJ
October 21, 2020	ZolmaxNews	Fulgent Genetics $FLGT Stock Rating Lowered by BidaskClub https://t.co/EGV7Wv3OOo
October 20, 2020	WeekHerald	Fulgent Genetics, Inc. $FLGT Sees Large Increase in Short Interest https://t.co/P4UTKfOsNM

Top 5 Lifetime News Headlines

Top Authors

• Archana Sinha
• View all authors

Verification history

• 1,451 days ago


• View all verifications